CoronaCentral
Dashboard
Recent
Epidemiology
Forecasting & Modelling
Infection Reports
Transmission
Contact Tracing
Prevalence
Prevention
Surveillance
Clinical
Clinical Reports
Risk Factors
Long Haul
Pediatrics
Medical Specialties
Recommendations
Imaging
Diagnostics
Healthcare Workers
Biology
Molecular Biology
Immunology
Model Systems & Tools
Non-human
Treatment
Therapeutics
Drug Targets
Vaccines
Clinical Trials
Medical Devices
Psychology
Policy
Health Policy
Communication
Inequality
Education
Other Articles
Reviews
Meta-analysis
Comments & Editorials
CDC Weekly Reports
Book Chapters
News
Non-medical
Retractions
Misinformation
Mentions
Drugs
Genes or Proteins
Genetic Variation
Locations
Medical Specialties
Prevention Methods
Risk Factors
Species
Symptoms
Test Types
Transmission Types
Vaccine Types
Viral Lineages
FAQs
Feedback
Select virus of interest
Immunology
Share
Research studying the interactions of the virus and the immune system
Published and Preprint Papers
Filter
Export
Title
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis.
Baseline gut microbiome features prior to SARS-CoV-2 infection are associated with host symptoms in and post COVID-19.
Examination of autoantibodies to type I interferon in patients suffering from long COVID.
The persistence of SARS-CoV-2 neutralizing antibodies after COVID-19: A one-year observation. Is a SARS-CoV-2 vaccination booster dose necessary?
Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022.
Investigating the impact of prior COVID-19 on IgG antibody and interferon γ responses after BBIBP-CorV vaccination in a disease endemic population: A prospective observational study.
Factors influencing neutralizing antibody response to the original SARS-CoV-2 virus and the Omicron variant in a high vaccination coverage country, a population-based study.
The correlation between humoral immune responses and severity of clinical symptoms in COVID-19 patients.
Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera.
Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants.
10
15
20
25
30